Active substance
Desmopressin
- SFDA 9
- US FDA 42
- Health Canada 10
- US price lines 5
- NHS prices 15
- WHO EML 1
- Safety 2
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| MINIRIN MELT 120 MCG LYOPHILIZED TABLET | 120 µg | Oral lyophilisate · Oral use | 30 Tablet Container | SAR 191.95 | NCE · Prescription | FERRING | Valid |
| MINIRIN MELT 240MCG ORAL LYOPHILISATE TABLET | 240 µg | Oral lyophilisate · Oral use | 30 Blister | SAR 338.50 | NCE · Prescription | FERRING Gmph | Valid |
| MINIRIN MILT 60 MCG LYOPHILIZED TABLET | 60 µg | Oral lyophilisate · Oral use | 30 Tablet Container | SAR 104.95 | NCE · Prescription | FERRING | Valid |
| MINIRIN NASAL SPRAY 0.1MG-ML | 0.1 mg/ml | Nasal spray, solution · Nasal use | 1 Pressurised container | SAR 111.40 | NCE · Prescription | FERRING | Valid |
| MINIRIN 0.1MG TAB | 0.1 mg | Tablet · Oral use | 30 Tablet Container | SAR 104.80 | NCE · Prescription | FERRING | Withdrawn by MAH · Not Marketed |
| MINIRIN 0.2MG TAB | 0.2 mg | Tablet · Oral use | 30 Tablet Container | SAR 171.90 | NCE · Prescription | FERRING | Withdrawn by MAH · Not Marketed |
| MINIRIN MILT 120 MCG LYOPHILIZED TABLET | 120 µg | Oral lyophilisate · Oral use | 30 Tablet Container | SAR 206.40 | NCE · Prescription | FERRING | Withdrawn by MAH · Not Marketed |
| MINIRIN MILT 60 MCG LYOPHILIZED TABLET | 60 µg | Oral lyophilisate · Oral use | 30 Tablet Container | SAR 127.90 | NCE · Prescription | FERRING | Withdrawn by MAH · Not Marketed |
| NOCDURNA 25MCG ORAL LYOPHILISATE TABLET | 25 µg | Oral lyophilisate · Oral use | 30 Blister | SAR 71.05 | NCE · Prescription | Ferring GmbH | Withdrawn by MAH · Not Marketed |
Indications — CHI Daman Drug Formulary
BENIGN PROSTATIC HYPERTROPHY; CENTRAL DIABETES INSIPIDUS; NOCTURNAL ENURESIS; URINARY INCONTINENCE AND OVERACTIVE BLADDER
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| DDAVP | 0.004MG/ML | injectable · injection | J MOLNER | Prescription | 30 Mar 1984 |
| DDAVP | 0.1MG; 0.2MG | tablet · oral | FERRING PHARMS INC | Prescription | 6 Sep 1995 |
| DESMOPRESSIN ACETATE | 0.004MG/ML | injectable · injection | MEITHEAL | Prescription | 15 Oct 1997 |
| DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION) | 0.01MG/SPRAY | spray, metered · nasal | APOTEX | Prescription | 27 Jan 2005 |
| DESMOPRESSIN ACETATE | 0.1MG; 0.2MG | tablet · oral | APOTEX | Prescription | 7 Mar 2006 |
| DESMOPRESSIN ACETATE | 0.1MG; 0.2MG | tablet · oral | HERITAGE PHARMA | Prescription | 26 May 2017 |
| DESMOPRESSIN ACETATE | 0.004MG/ML | injectable · injection | SAGENT PHARMS INC | Prescription | 22 Aug 2017 |
| DESMOPRESSIN ACETATE | 0.004MG/ML | injectable · injection | SAGENT PHARMS INC | Prescription | 22 Aug 2017 |
| DESMOPRESSIN ACETATE (NEEDS NO REFRIGERATION) | 0.01MG/SPRAY | spray, metered · nasal | ZYDUS PHARMS | Prescription | 3 Oct 2017 |
| DESMOPRESSIN ACETATE | 0.1MG; 0.2MG | tablet · oral | ABHAI LLC | Prescription | 28 Jan 2019 |
| DESMOPRESSIN ACETATE | 0.1MG; 0.2MG | tablet · oral | NOVAST LABS | Prescription | 6 Jun 2019 |
| DESMOPRESSIN ACETATE | 0.004MG/ML | injectable · injection | UBI | Prescription | 14 Feb 2020 |
| DESMOPRESSIN ACETATE | 0.004MG/ML | injectable · injection | UBI | Prescription | 17 Sep 2020 |
| DESMOPRESSIN ACETATE | 0.004MG/ML | injectable · injection | DR REDDYS | Prescription | 19 Aug 2022 |
| DESMOPRESSIN ACETATE | 0.004MG/ML | injectable · injection | GLAND | Prescription | 16 Nov 2022 |
| DESMOPRESSIN ACETATE | 0.004MG/ML | injectable · injection | GLAND | Prescription | 20 Mar 2023 |
| DESMOPRESSIN ACETATE | 0.1MG; 0.2MG | tablet · oral | AUROBINDO PHARMA | Prescription | 21 Mar 2024 |
| DESMODA | 0.05MG/ML | solution · oral | ETON | Prescription | 25 Feb 2026 |
| DESMOPRESSIN ACETATE | 0.004MG/ML | injectable · injection | CAPLIN | Prescription | 27 Feb 2026 |
| DDAVP | 0.01% | solution · nasal | FERRING PHARMS INC | Discontinued | 21 Feb 1978 |
| DDAVP | 0.01MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | spray, metered · nasal | FERRING PHARMS INC | Discontinued | 21 Feb 1978 |
| DDAVP (NEEDS NO REFRIGERATION) | 0.01MG/SPRAY **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | spray, metered · nasal | FERRING PHARMS INC | Discontinued | 21 Feb 1978 |
| DDAVP | 0.015MG/ML | injectable · injection | J MOLNER | Discontinued | 30 Mar 1984 |
| CONCENTRAID | 0.01% | solution · nasal | FERRING | Discontinued | 26 Dec 1990 |
| STIMATE | 0.15MG/SPRAY | spray, metered · nasal | FERRING PHARMS INC | Discontinued | 7 Mar 1994 |
17 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| APO-DESMOPRESSIN | 02284030 | 0.1 MG | TABLET · ORAL | APOTEX INC |
| APO-DESMOPRESSIN | 02284049 | 0.2 MG | TABLET · ORAL | APOTEX INC |
| BIPAZEN | 02513579 | 4 MCG / ML | SOLUTION · INTRAVENOUS; SUBCUTANEOUS; INTRAMUSCULAR | KVR PHARMACEUTICALS INC. |
| DDAVP INJ 4MCG/ML | 00873993 | 4 MCG / ML | LIQUID · INTRAMUSCULAR; SUBCUTANEOUS; INTRAVENOUS | FERRING INC |
| DDAVP MELT | 02284995 | 60 MCG | TABLET (ORALLY-DISINTEGRATING) · SUBLINGUAL | FERRING INC |
| DDAVP MELT | 02285002 | 120 MCG | TABLET (ORALLY-DISINTEGRATING) · SUBLINGUAL | FERRING INC |
| DESMOPRESSIN SPRAY | 02242465 | 10 MCG / ACT | SPRAY (METERED-DOSE) · NASAL | AA PHARMA INC |
| OCTOSTIM LIQ INJ. 15MCG/ML | 02024179 | 15 MCG / ML | SOLUTION · SUBCUTANEOUS; INTRAVENOUS | FERRING INC |
| PMS-DESMOPRESSIN | 02304368 | 0.1 MG | TABLET · ORAL | PHARMASCIENCE INC |
| PMS-DESMOPRESSIN | 02304376 | 0.2 MG | TABLET · ORAL | PHARMASCIENCE INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | DESMOPRESSIN 10 MCG/0.1 ML SPR | $10.11078 | per ML | 23 Sep 2026 |
| US NADAC | DESMOPRESSIN 40 MCG/10 ML VIAL | $19.14792 | per ML | 7 Oct 2026 |
| US NADAC | DESMOPRESSIN AC 4 MCG/ML VIAL | $19.14792 | per ML | 23 Sep 2026 |
| US NADAC | DESMOPRESSIN ACETATE 0.1 MG TB | $0.24294 | per EA | 23 Sep 2026 |
| US NADAC | DESMOPRESSIN ACETATE 0.2 MG TB | $0.37257 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Desmopressin 100microgram tablets | £38.32 | 90 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Desmopressin 10micrograms/dose nasal spray | £48.61 | 60 dose | 1 Oct 2026 |
| NHS Drug Tariff | Desmopressin 120microgram oral lyophilisates sugar free | £30.34 | 30 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Desmopressin 120microgram oral lyophilisates sugar free | £101.07 | 100 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Desmopressin 120microgram sublingual tablets sugar free | £10.97 | 30 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Desmopressin 200microgram tablets | £17.99 | 30 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Desmopressin 240microgram oral lyophilisates sugar free | £60.68 | 30 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Desmopressin 240microgram sublingual tablets sugar free | £20.03 | 30 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Desmopressin 240microgram sublingual tablets sugar free | £185.66 | 100 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Desmopressin 25microgram oral lyophilisates sugar free | £15.16 | 30 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Desmopressin 360micrograms/ml oral solution sugar free | £19.95 | 15 ml | 1 Oct 2026 |
| NHS Drug Tariff | Desmopressin 4micrograms/1ml solution for injection ampoules | £13.16 | 10 ampoule | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 10.2. Medicines affecting coagulation · core
Haemophilia A; Von Willebrand disease
Parenteral > General injections > IV: 4 µg per mL in 1 mL ampoule (acetate) | Local > Nasal > Spray: 150 µg per actuation (acetate)
Safety signals and safety-related labeling changes
- US FDA 29 Oct 2019 DESMOPRESSIN ACETATE — safety-related labeling change
Labeling sections changed: Use in Specific Populations - US FDA 29 May 2018 MINIRIN — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Drug Interactions; Use in Specific Populations; Patient Counseling Information / Patient Information / Medication Guide
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.